Document is current

Article History

Received: 24 April 2020

Revised: 24 June 2020

Accepted: 27 June 2020

First Online: 3 July 2020

Compliance with ethical standards

:

: Disclosure of potential conflicts of interest: F.Corvi, M.Cozzi and L.Pace declare no conflict of interest. A. Invernizzi: Allergan (financial support), Novartis (consultant), and Bayer (consultant). S.R. Sadda: Allergan (consultant, financial support), Carl Zeiss Meditec (financial support), Genentech (consultant, financial support), Amgen (consultant), Novartis (consultant), Optos (consultant, financial support), Centervue (consultant), Heidelberg (consultant), Regeneron (financial support), and Oxurion (consultant). G. Staurenghi: Heidelberg Engineering (consultant), Quantel Medical (consultant), Centervue (consultant), Carl Zeiss Meditec (consultant), Alcon (consultant), Allergan (consultant), Bayer (consultant), Boheringer (consultant), Genentech (consultant), GSK (consultant), Novartis (consultant), and Roche (consultant), and has received grant support from Optos (financial support), Optovue (financial support), and Centervue (financial support).

: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

: Informed consent was obtained from all individual participants included in the study.